发明名称 |
Antibodies for determining the prothrombin fragment F2/F1+2 in a homogeneous immunoassay |
摘要 |
The present invention is in the area of coagulation analysis and relates to antibodies which bind specifically to an immune complex of prothrombin fragment F2/F1+2 and an F2/F1+2 neoepitope-specific antibody fragment, and to the preparation and the use thereof in methods for determining F2/F1+2. |
申请公布号 |
US9096674(B2) |
申请公布日期 |
2015.08.04 |
申请号 |
US200912566464 |
申请日期 |
2009.09.24 |
申请人 |
Siemens Healthcare Diagnostics Products GmbH |
发明人 |
Ehm Matthias;Fischer Bodo;Althaus Harald;Barten Roland;Teigelkamp Stefan |
分类号 |
C07K16/36;C07K16/42;C12N5/20;C12P21/08;G01N33/563;G01N33/573;G01N33/86;C12N9/74 |
主分类号 |
C07K16/36 |
代理机构 |
Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P. |
代理人 |
Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P. |
主权项 |
1. An isolated immune complex comprising an antibody fragment and a peptide, wherein:
the peptide includes at least a complete prothrombin fragment F2; the carboxy terminus of the complete prothrombin fragment F2 of the peptide is bound to the antibody fragment; the antibody fragment has specificity for a carboxy-terminal neoepitope of the prothrombin fragment F2 and/or fragment F1+2; and wherein the antibody fragment is a fragment of a monoclonal antibody made by hybridoma cell line DSM ACC 2911. |
地址 |
Marburg DE |